Redwood Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$855K Sell
14,098
-2,260
-14% -$132K 0.11% 178
2025
Q4
$882K Sell
16,358
-9,734
-37% -$468K 0.1% 198
2025
Q3
$1.18M Sell
26,092
-13,137
-33% -$614K 0.13% 212
2025
Q2
$1.82M Buy
39,229
+5,937
+18% +$291K 0.19% 98
2025
Q1
$2.03M Sell
33,292
-9,217
-22% -$537K 0.22% 77
2024
Q4
$2.4M Sell
42,509
-98,724
-70% -$5.52M 0.23% 67
2024
Q3
$7.2M Sell
141,233
-10,217
-7% -$479K 0.64% 18
2024
Q2
$6.75M Buy
151,450
+7,338
+5% +$328K 0.58% 34
2024
Q1
$7.82M Buy
144,112
+8,554
+6% +$436K 0.74% 23
2023
Q4
$6.96M Buy
135,558
+126,893
+1,464% +$6.66M 0.64% 24
2023
Q3
$503K Buy
+8,665
New +$531K 0.04% 269
2023
Q2
Sell
-24,074
Closed -$1.67M 233
2023
Q1
$1.67M Buy
24,074
+21,158
+726% +$1.49M 0.18% 135
2022
Q4
$210K Buy
+2,916
New +$220K 0.03% 244
2022
Q3
Sell
-16,005
Closed -$1.23M 212
2022
Q2
$1.23M Buy
+16,005
New +$1.22M 0.21% 108
2022
Q1
Sell
-29,344
Closed -$1.83M 278
2021
Q4
$1.83M Buy
+29,344
New +$1.72M 0.24% 90
2020
Q1
Sell
-6,925
Closed -$445K 160
2019
Q4
$445K Buy
6,925
+459
+7% +$26.3K 0.11% 186
2019
Q3
$328K Sell
6,466
-282
-4% -$13.3K 0.09% 210
2019
Q2
$306K Buy
+6,748
New +$314K 0.09% 221

Other funds holding BMY

Redwood Investment Management's BMY Position: Q1 2026 in Review

Redwood Investment Management reduced its Bristol-Myers Squibb (BMY) stake by 14% in Q1 2026, selling an estimated $132K and leaving 14,098 shares worth $855K. The position accounts for 0.11% of the portfolio, ranked #178.

Redwood Investment Management first reported a position in BMY in Q2 2019 and has held it in 18 quarters since. The position peaked at $7.82M in Q1 2024. 2,521 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Redwood Investment Management held 14,098 shares of Bristol-Myers Squibb worth $855K as of Q1 2026.
  • Redwood Investment Management sold 2,260 Bristol-Myers Squibb shares in Q1 2026, an estimated $132K.
  • Bristol-Myers Squibb made up 0.11% of Redwood Investment Management's portfolio in Q1 2026, its #178 holding.
  • Redwood Investment Management first reported a position in Bristol-Myers Squibb in Q2 2019 and has held it in 18 quarters since.
  • Redwood Investment Management's Bristol-Myers Squibb position peaked at $7.82M in Q1 2024.
  • 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Redwood Investment Management's 13F filing for Q1 2026, filed 14 May 2026.